Study Favors PET-CT Scans Over Whole-Body MRI In Determining Response To Myeloma Treatment

October 15, 2012

Results of a recent German study suggest that PET-CT scans may be more reliable than whole-body MRI in determining the remission status of multiple myeloma patients after stem cell transplantation.

The investigators conclude that both PET-CT and whole-body MRI provide useful information about a patient’s disease status.  However, MRI often incorrectly detects activity in bone lesions that persist after treatment.  They therefore state that PET-CT may be better than MRI for determining remission status.